• Menu
  • Contenu
  • Recherche
  • Pied de page
Home

Main navigation

'Logo de la CCNE

Comité consultatif national d'éthique

Pour les sciences de la vie et de la santé

  • Résultats de la recherche

  • french version
    fr
    english version
    en
  • News
  • Rapport d'activité 2023-2024
  • Committee
    • Aims
    • Ethics
    • Projects
    • The organisation
    • NCEC's Members
  • Topics
    • Medicine
    • Ages of life
    • Health, society
    • Digital
    • Research, legislation, ethics
  • Ethics elsewhere
    • Ethics in France
    • International ethics
  • CNPEN

  • Résultats de la recherche

  • News
  • Rapport d'activité 2023-2024
    • Aims Ethics Projects The organisation NCEC's Members
    • Medicine Ages of life Health, society Digital Research, legislation, ethics
    • Ethics in France International ethics
  • CNPEN
  1. Home
  2. Opinion 32 on the appropriateness and type of trial to be conducted to clarify the indications for Centoxin

Research

Opinion 32 on the appropriateness and type of trial to be conducted to clarify the indications for Centoxin



Opinion on the appropriateness and type of trial to be conducted to clarify the indications for Centoxin. Report. (1992-07-10)

"Download Opinion 32 on Appropriateness and Type of Trial for Clarifying Centoxin Indications
pdf - 34.37 KB
  • Press
  • Agenda
  • Legal notices
  • Accessibility: partially compliant
  • Contact us
  • Gestion des cookies
  • Sitemap